CRC.9 | NRG-GI005
Circulating Tumor DNA Testing in Predicting Treatment for Patients With Stage IIA Colon Cancer After Surgery
Line of Therapy
o Active Comparator: Arm I (blood stored and tested for ctDNA later) - Patients undergo active surveillance.
o Experimental: Arm II (blood tested for ctDNA at baseline)